Cargando…

CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells

Conventional reprogramming methods rely on the ectopic expression of transcription factors to reprogram somatic cells into induced pluripotent stem cells (iPSCs). The forced expression of transcription factors may lead to off-target gene activation and heterogeneous reprogramming, resulting in the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sokka, Joonas, Yoshihara, Masahito, Kvist, Jouni, Laiho, Laura, Warren, Andrew, Stadelmann, Christian, Jouhilahti, Eeva-Mari, Kilpinen, Helena, Balboa, Diego, Katayama, Shintaro, Kyttälä, Aija, Kere, Juha, Otonkoski, Timo, Weltner, Jere, Trokovic, Ras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828555/
https://www.ncbi.nlm.nih.gov/pubmed/35063129
http://dx.doi.org/10.1016/j.stemcr.2021.12.017
_version_ 1784647873322811392
author Sokka, Joonas
Yoshihara, Masahito
Kvist, Jouni
Laiho, Laura
Warren, Andrew
Stadelmann, Christian
Jouhilahti, Eeva-Mari
Kilpinen, Helena
Balboa, Diego
Katayama, Shintaro
Kyttälä, Aija
Kere, Juha
Otonkoski, Timo
Weltner, Jere
Trokovic, Ras
author_facet Sokka, Joonas
Yoshihara, Masahito
Kvist, Jouni
Laiho, Laura
Warren, Andrew
Stadelmann, Christian
Jouhilahti, Eeva-Mari
Kilpinen, Helena
Balboa, Diego
Katayama, Shintaro
Kyttälä, Aija
Kere, Juha
Otonkoski, Timo
Weltner, Jere
Trokovic, Ras
author_sort Sokka, Joonas
collection PubMed
description Conventional reprogramming methods rely on the ectopic expression of transcription factors to reprogram somatic cells into induced pluripotent stem cells (iPSCs). The forced expression of transcription factors may lead to off-target gene activation and heterogeneous reprogramming, resulting in the emergence of alternative cell types and aberrant iPSCs. Activation of endogenous pluripotency factors by CRISPR activation (CRISPRa) can reduce this heterogeneity. Here, we describe a high-efficiency reprogramming of human somatic cells into iPSCs using optimized CRISPRa. Efficient reprogramming was dependent on the additional targeting of the embryo genome activation-enriched Alu-motif and the miR-302/367 locus. Single-cell transcriptome analysis revealed that the optimized CRISPRa reprogrammed cells more directly and specifically into the pluripotent state when compared to the conventional reprogramming method. These findings support the use of CRISPRa for high-quality pluripotent reprogramming of human cells.
format Online
Article
Text
id pubmed-8828555
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88285552022-02-14 CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells Sokka, Joonas Yoshihara, Masahito Kvist, Jouni Laiho, Laura Warren, Andrew Stadelmann, Christian Jouhilahti, Eeva-Mari Kilpinen, Helena Balboa, Diego Katayama, Shintaro Kyttälä, Aija Kere, Juha Otonkoski, Timo Weltner, Jere Trokovic, Ras Stem Cell Reports Article Conventional reprogramming methods rely on the ectopic expression of transcription factors to reprogram somatic cells into induced pluripotent stem cells (iPSCs). The forced expression of transcription factors may lead to off-target gene activation and heterogeneous reprogramming, resulting in the emergence of alternative cell types and aberrant iPSCs. Activation of endogenous pluripotency factors by CRISPR activation (CRISPRa) can reduce this heterogeneity. Here, we describe a high-efficiency reprogramming of human somatic cells into iPSCs using optimized CRISPRa. Efficient reprogramming was dependent on the additional targeting of the embryo genome activation-enriched Alu-motif and the miR-302/367 locus. Single-cell transcriptome analysis revealed that the optimized CRISPRa reprogrammed cells more directly and specifically into the pluripotent state when compared to the conventional reprogramming method. These findings support the use of CRISPRa for high-quality pluripotent reprogramming of human cells. Elsevier 2022-01-20 /pmc/articles/PMC8828555/ /pubmed/35063129 http://dx.doi.org/10.1016/j.stemcr.2021.12.017 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sokka, Joonas
Yoshihara, Masahito
Kvist, Jouni
Laiho, Laura
Warren, Andrew
Stadelmann, Christian
Jouhilahti, Eeva-Mari
Kilpinen, Helena
Balboa, Diego
Katayama, Shintaro
Kyttälä, Aija
Kere, Juha
Otonkoski, Timo
Weltner, Jere
Trokovic, Ras
CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
title CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
title_full CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
title_fullStr CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
title_full_unstemmed CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
title_short CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
title_sort crispr activation enables high-fidelity reprogramming into human pluripotent stem cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828555/
https://www.ncbi.nlm.nih.gov/pubmed/35063129
http://dx.doi.org/10.1016/j.stemcr.2021.12.017
work_keys_str_mv AT sokkajoonas crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT yoshiharamasahito crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT kvistjouni crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT laiholaura crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT warrenandrew crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT stadelmannchristian crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT jouhilahtieevamari crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT kilpinenhelena crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT balboadiego crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT katayamashintaro crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT kyttalaaija crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT kerejuha crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT otonkoskitimo crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT weltnerjere crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells
AT trokovicras crispractivationenableshighfidelityreprogrammingintohumanpluripotentstemcells